Association of PAX4 genetic variants with oral antidiabetic drugs efficacy in Chinese type 2 diabetes patients

Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4

(2013) R. C. W. Ma et al.   DIABETOLOGIA

Defective PAX4 R192H transcriptional repressor activities associated with maturity onset diabetes of the young and early onset-age of type 2 diabetes

(2012) Suwattanee Kooptiwut et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Effects of KCNQ1 Polymorphisms on the Therapeutic Efficacy of Oral Antidiabetic Drugs in Chinese Patients With Type 2 Diabetes

(2011) W Yu et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians

(2011) Yoon Shin Cho et al.   NATURE GENETICS

Association ofKCNJ11andABCC8genetic polymorphisms with response to repaglinide in Chinese diabetic patients1

(2008) Ya-yi HE et al.   ACTA PHARMACOLOGICA SINICA

Effects of ABCA1 variants on rosiglitazone monotherapy in newly diagnosed type 2 diabetes patients

(2008) Jie WANG et al.   ACTA PHARMACOLOGICA SINICA

Rosiglitazone stimulates the release and synthesis of insulin by enhancing GLUT-2, glucokinase and BETA2/NeuroD expression

(2008) Hyo-Sup Kim et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

In Vivoandin VitroStudies of a Functional Peroxisome Proliferator-activated Receptor γ Response Element in the Mousepdx-1Promoter

(2008) Dhananjay Gupta et al.   JOURNAL OF BIOLOGICAL CHEMISTRY